ReShape Lifesciences Debt 2024

ReShape Lifesciences Aktienanalyse

What does ReShape Lifesciences do?

ReShape Lifesciences Inc is a medical company that was founded in 2018 and is headquartered in San Clemente, California. The company is involved in the development and marketing of medical devices for the treatment of obesity and metabolic disorders. The company's business model focuses on innovative medical devices and services for the treatment of obesity and metabolic disorders. The company's main goal is to help patients improve their weight and health in a non-surgical way. The company offers not only medical devices but also services such as physician consulting, training for medical professionals, and patient support. The company's core products include the ReShape Vest, a non-invasive weight loss therapy approach, and the ReShape Duo System, a secondary gastric balloon system used in combination with a dietary program to support weight reduction. The company also offers the ReShape Care Plan, a comprehensive program for patients with obesity that is managed by a multidisciplinary team. The program includes individual sessions with a certified dietitian and a behavioral coach to motivate patients through concrete guidance for weight reduction. ReShape Lifesciences is dedicated to research and development of medical devices and services that help patients in weight reduction and improving their health. The company aims to create an affordable, safe, and effective treatment for obesity patients in an innovative manner that aligns with healthcare reform. ReShape Lifesciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding ReShape Lifesciences's Debt Structure

ReShape Lifesciences's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing ReShape Lifesciences's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to ReShape Lifesciences’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in ReShape Lifesciences’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about ReShape Lifesciences Stock

What is the debt of ReShape Lifesciences this year?

ReShape Lifesciences has a debt level of -4.46 USD this year.

What was the debt of ReShape Lifesciences compared to the previous year?

The debt of ReShape Lifesciences has increased by 15.52% compared to the previous year increased.

What are the consequences of high debt for investors in ReShape Lifesciences?

High debt can pose a risk for investors of ReShape Lifesciences, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of ReShape Lifesciences?

Low debt means that ReShape Lifesciences has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from ReShape Lifesciences affect the company?

An increase in debt of ReShape Lifesciences can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of ReShape Lifesciences affect the company?

A reduction in debt of ReShape Lifesciences can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of ReShape Lifesciences?

Some factors that can influence the debt of ReShape Lifesciences include investments, acquisitions, operating costs, and revenue development.

Why are the debts of ReShape Lifesciences so important for investors?

The debts of ReShape Lifesciences are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can ReShape Lifesciences take to change the debt?

To change the debt, ReShape Lifesciences can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does ReShape Lifesciences pay?

Over the past 12 months, ReShape Lifesciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ReShape Lifesciences is expected to pay a dividend of 0 USD.

What is the dividend yield of ReShape Lifesciences?

The current dividend yield of ReShape Lifesciences is .

When does ReShape Lifesciences pay dividends?

ReShape Lifesciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ReShape Lifesciences?

ReShape Lifesciences paid dividends every year for the past 0 years.

What is the dividend of ReShape Lifesciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ReShape Lifesciences located?

ReShape Lifesciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von ReShape Lifesciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ReShape Lifesciences from 5/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/28/2024.

When did ReShape Lifesciences pay the last dividend?

The last dividend was paid out on 5/28/2024.

What was the dividend of ReShape Lifesciences in the year 2023?

In the year 2023, ReShape Lifesciences distributed 0 USD as dividends.

In which currency does ReShape Lifesciences pay out the dividend?

The dividends of ReShape Lifesciences are distributed in USD.